rs34873891

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_013335.4(GMPPA):​c.190C>T​(p.Pro64Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00287 in 1,613,098 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 11 hom. )

Consequence

GMPPA
NM_013335.4 missense

Scores

2
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.887

Publications

3 publications found
Variant links:
Genes affected
GMPPA (HGNC:22923): (GDP-mannose pyrophosphorylase A) This gene is thought to encode a GDP-mannose pyrophosphorylase. This enzyme catalyzes the reaction which converts mannose-1-phosphate and GTP to GDP-mannose which is involved in the production of N-linked oligosaccharides. [provided by RefSeq, Jul 2008]
ASIC4-AS1 (HGNC:40960): (ASIC4 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0066054463).
BP6
Variant 2-219501527-C-T is Benign according to our data. Variant chr2-219501527-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 388353.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0022 (335/152280) while in subpopulation NFE AF = 0.0031 (211/68022). AF 95% confidence interval is 0.00276. There are 0 homozygotes in GnomAd4. There are 147 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GMPPANM_013335.4 linkc.190C>T p.Pro64Ser missense_variant Exon 4 of 13 ENST00000313597.10 NP_037467.2 Q96IJ6-1A0A384MDS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GMPPAENST00000313597.10 linkc.190C>T p.Pro64Ser missense_variant Exon 4 of 13 1 NM_013335.4 ENSP00000315925.6 Q96IJ6-1

Frequencies

GnomAD3 genomes
AF:
0.00220
AC:
335
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00801
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00310
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00229
AC:
577
AN:
251478
AF XY:
0.00235
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.000954
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00873
Gnomad NFE exome
AF:
0.00293
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00294
AC:
4301
AN:
1460818
Hom.:
11
Cov.:
29
AF XY:
0.00285
AC XY:
2074
AN XY:
726838
show subpopulations
African (AFR)
AF:
0.000508
AC:
17
AN:
33460
American (AMR)
AF:
0.000738
AC:
33
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000306
AC:
8
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86236
European-Finnish (FIN)
AF:
0.00792
AC:
423
AN:
53420
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5766
European-Non Finnish (NFE)
AF:
0.00331
AC:
3676
AN:
1111016
Other (OTH)
AF:
0.00234
AC:
141
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
193
386
578
771
964
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00220
AC:
335
AN:
152280
Hom.:
0
Cov.:
32
AF XY:
0.00197
AC XY:
147
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.000626
AC:
26
AN:
41558
American (AMR)
AF:
0.000588
AC:
9
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00801
AC:
85
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00310
AC:
211
AN:
68022
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00216
Hom.:
2
Bravo
AF:
0.00147
TwinsUK
AF:
0.00539
AC:
20
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00302
AC:
26
ExAC
AF:
0.00238
AC:
289
EpiCase
AF:
0.00273
EpiControl
AF:
0.00231

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Alacrima, achalasia, and intellectual disability syndrome Benign:2
Mar 16, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
May 01, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28820871) -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GMPPA: BP4, BS2 -

not specified Benign:1
Apr 19, 2017
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1,BP4; This alteration has an allele frequency that is greater than expected for the associated disease, and is predicted to be tolerated by multiple functional prediction tools. -

GMPPA-related disorder Benign:1
Mar 29, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
10
DANN
Benign
0.93
DEOGEN2
Benign
0.40
T;.;T;T;.;T;T;.
Eigen
Benign
-0.52
Eigen_PC
Benign
-0.41
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.89
.;D;.;.;D;D;D;D
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.0066
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
-0.41
N;N;N;N;.;.;N;.
PhyloP100
0.89
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.090
N;N;N;N;N;N;N;.
REVEL
Benign
0.16
Sift
Benign
0.42
T;T;T;T;T;T;T;.
Sift4G
Benign
0.72
T;T;T;T;T;T;T;T
Polyphen
0.0
B;B;B;B;.;.;B;.
Vest4
0.27
MVP
0.72
MPC
0.39
ClinPred
0.0085
T
GERP RS
-2.4
Varity_R
0.040
gMVP
0.45
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34873891; hg19: chr2-220366249; COSMIC: COSV58007129; COSMIC: COSV58007129; API